Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Willem Cox

PhD student
Willem Cox

Defining specific vulnerabilities in relapsed TP53-mutated Acute Lymphoblastic Leukemia

Phone 088 97 27682

P53 is a protein encoded by the TP53 gene and functions as a tumor suppressor controlling cell cycle regulation, genomic stability and the induction of apoptosis and. Of all children with relapsed Acute Lymphoblastic Leukemia (ALL), about 12% carry alterations affecting TP53 and this represents a strong and independent predictor of treatment failure. To date, little is known about what makes TP53-aberrant leukemias difficult to treat. The aim of this project is to obtain insights in the biology of TP53 deleted or mutated ALL and to identify specific vulnerabilities that can be targeted to provide new therapy options for this ‘very high-risk’ patient group.